| About the author: |
Y. H. Hajiyeva |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Taking into account the prevalence of arterial hypertension, its role in the development of cardiovascular diseases and mortality, increasing the effectiveness of the treatment of this pathology remains a topical issue of modern medicine. The purpose of the study is to determine the relationship between elevated blood cholesterol levels and masked arterial hypertension. The study involved 827 people aged 19 to 71, these patients without a history of arterial hypertension were divided into 2 groups: 1) with elevated blood cholesterol levels (n=375); 2) with a normal level of cholesterol in the blood (n=186) – the control group. There were no symptoms of arterial hypertension and the main risk factors (smoking, alcohol, obesity, low physical activity). The average blood cholesterol level was 6.16±0.22 mmol/l in the first group and 4.69±0.18 mmol/l in the control group. In the first group, arterial hypertension was detected in 19 people out of 138 (mean systolic pressure 152.6±4.3 mm Hg, diastolic 97.6±3.7 mm Hg), in 14 of them the cholesterol level exceeded 7.5 mmol/l, in the control group the result was negative. Thus, the use of modern devices makes it possible to detect masked arterial hypertension and carry out appropriate preventive measures. |
| Tags |
cholesterol, metabolic disorders, masked arterial hypertension, risk factors |
| Bibliography |
- Yezhov MV, Barbarash OL, Voevoda MI, Gurevich VS, Vezikova NN, Sadykova DI, et al. Proekt Rossiyskogo natsionalnogo obshchestva ateroskleroza. Organizatsiya tsentrov lipidov v Rossiyskoy Federatsii – novye vozmozhnosti. Rossiyskiy kardiologicheskiy zhurnal. 2021; 26(6):4489. doi:10.15829/1560-4071-2021-4489 [In Russian]
- Lyamina NP, Nalibaeva AV, Malinova LI. Kliniko-laboratornye i prognosticheskie osobennosti maskirovannoy arterialnoy gipertenzii u rabotayushchikh zhenshchin srednego vozrasta. Arterialnaya gipertenziya. 2015; 21(1): 93–99. https://doi.org/10.18705/1607-419X-2015-21-1 [In Russian]
- Lyamina NP, Nalibaeva AV, Senchihin VN, Lipchanskaya TP. Maskirovannaya arterialnaya gipertenziya u lits molodogo vozrasta: vyyavlyaemost, vyrazhennost kardiovaskulyarnykh faktorov riska i prognoz s uchetom gendernykh razlichiy. Rossiyskiy kardiologicheskiy zhurnal. 2017;(4):7–12. https://doi.org/10.15829/1560-4071-2017-4-7-12 [In Russian]
- Nikitina NM, Romanova TA, Rebrov AP. Maskirovannaya arterialnaya gipertenziya: aktualna li problema dlya bolnykh s revmatoidnym artritom. Arterialnaya gipertenziya. 2016; 22(4): 364–369. ISSN 2411-8524 (Online) [In Russian]
- Nikitina NM, Romanova TA, Rebrov AP. Sutochnoe monitorirovaniye arterialnogo davleniya kak metod ranney diagnostiki arterialnoy gipertenzii u bolnykh revmatoidnym artritom. Rossiyskiy kordiologicheskiy zhurnal. 2017; 4:29–34. https://doi.org/10.15829/1560-4071-2017-4-29-34 [In Russian]
- Polupanov AG, Halmatov AN, Altymysheva AT. Rasprostranennost serdechno-sosudistykh faktorov riska sredi zhiteley Kyrgyzskoy Respubliki trudosposobnogo vozrasta (po dannym mezhdunarodnogo issledovaniya “INTERE-PID”) Chast' III. Rasprostranennost metabolicheskikh faktorov riska. Tsentralno-aziatskiy meditsinskiy zhurnal. 2013; 4:213–220. [In Russian]
- Reshetnikov VA, Kozlov VV, Royuk VV.Obosnovanie modeli sovershenstvovaniya organizatsii meropriyatiy po ranney diagnostike i profilaktike arterialnoy gipertenzii. Kazanskiy meditsinskiy zhurnal. 2016; 5:755–758. DOI: https://doi.org/10.17750/KMJ2016-755 [In Russian]
- Sirenko YuN, Radchenko AD, Rekovec OL. Faktory riska, vliyayushchie na prognoz u bolnykh s arterialnoy gipertenziey. Arterialnaya gipertenziya. 2018; 2:59–69. DOI: 10.22141/2224-1485.2.58.2018.131068 [In Russian]
- Skoryatina IA. Sovremennye vzglyady na terapiyu dislipidemii, sochetayushchejsya s arterialnoy gipertoniey. Ulyanovskiy mediko-biologicheskiy zhurnal. 2016; 2:8–19. [In Russian]
- Utkina EA, Afanasyeva OI, Ezhov MV. Svyaz razlichnykh podfraktsiy lipoproteidov s koronarnym aterosklerozom u muzhchin srednego vozrasta, poluchavshikh terapiyu statinami. Kardiologicheskiy vestnik. 2014; 9(1): 68–76. [In Russian]
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. September 2019; 140, 11, 563–595. https://doi.org/10.1161/CIR.0000000000000677
- Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Rev Esp Cardiol (Engl Ed). 2017 Feb; 70(2):115. English. doi: 10.1016/j.rec.2017.01.002. PMID: 29389351.
- Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization; 2011 [cited 2013 Jan 11]. 155 p. Available from: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=21049&Itemid=
- Leong DP, Smyth A, Teo KK, McKee M, Rangarajan S, Pais P, et al. INTERHEART Investigators. Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case-control study. Circulation. 2014 Jul 29;130(5):390–8. DOI: 10.1161/CIRCULATIONAHA.113.007627. Epub 2014 Jun 13. PMID: 24928682.
- Stone NJ, Robinson JG, Lichtenstein AH. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guideline. Circulation. 2014; 129(2):1–45. DOI: 10.1161/01.cir.0000437738.63853.7a
|
| Publication of the article |
«World of Medicine and Biology» №1(79), 2022 year, 039-043 pages, index UDK 616.12–085 |
| DOI |
10.26724/2079-8334-2022-1-79-39-43 |
